Anti-UCMA/ C10orf49/ GRP functional antibody

Anti-UCMA/ C10orf49/ GRP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to UCMA/UCMA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1355-Ab-1/ GM-Tg-hg-SE1355-Ab-2Anti-Human UCMA monoclonal antibodyHuman
GM-Tg-rg-SE1355-Ab-1/ GM-Tg-rg-SE1355-Ab-2Anti-Rat UCMA monoclonal antibodyRat
GM-Tg-mg-SE1355-Ab-1/ GM-Tg-mg-SE1355-Ab-2Anti-Mouse UCMA monoclonal antibodyMouse
GM-Tg-cynog-SE1355-Ab-1/ GM-Tg-cynog-SE1355-Ab-2Anti-Cynomolgus/ Rhesus macaque UCMA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1355-Ab-1/ GM-Tg-felg-SE1355-Ab-2Anti-Feline UCMA monoclonal antibodyFeline
GM-Tg-cang-SE1355-Ab-1/ GM-Tg-cang-SE1355-Ab-2Anti-Canine UCMA monoclonal antibodyCanine
GM-Tg-bovg-SE1355-Ab-1/ GM-Tg-bovg-SE1355-Ab-2Anti-Bovine UCMA monoclonal antibodyBovine
GM-Tg-equg-SE1355-Ab-1/ GM-Tg-equg-SE1355-Ab-2Anti-Equine UCMA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1355-Ab-1/ GM-Tg-hg-SE1355-Ab-2; GM-Tg-rg-SE1355-Ab-1/ GM-Tg-rg-SE1355-Ab-2;
GM-Tg-mg-SE1355-Ab-1/ GM-Tg-mg-SE1355-Ab-2; GM-Tg-cynog-SE1355-Ab-1/ GM-Tg-cynog-SE1355-Ab-2;
GM-Tg-felg-SE1355-Ab-1/ GM-Tg-felg-SE1355-Ab-2; GM-Tg-cang-SE1355-Ab-1/ GM-Tg-cang-SE1355-Ab-2;
GM-Tg-bovg-SE1355-Ab-1/ GM-Tg-bovg-SE1355-Ab-2; GM-Tg-equg-SE1355-Ab-1/ GM-Tg-equg-SE1355-Ab-2
Products NameAnti-UCMA monoclonal antibody
Formatmab
Target NameUCMA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-UCMA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1355-Ag-1Recombinant multi-species UCMA/ C10orf49/ GRP protein
    ORF Viral VectorpGMLPm000846mouse Ucma Lentivirus plasmid
    ORF Viral VectorvGMLPm000846mouse Ucma Lentivirus particle


    Target information

    Target IDGM-SE1355
    Target NameUCMA
    Gene ID221044,68527,291312,698795,478002,101097989,615924,100069244
    Gene Symbol and Synonyms1110017I16Rik,C10orf49,GRP,GRP/UCMA,RGD1308977,UCMA
    Uniprot AccessionQ8WVF2,B9TQX4
    Uniprot Entry NameUCMA_HUMAN,UCMA_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165623
    Target ClassificationN/A

    The target: UCMA, gene name: UCMA, also named as C10orf49, GRP, GRP/UCMA. This gene encodes a chondrocyte-specific, highly charged protein that is abundantly expressed in the upper immature zone of fetal and juvenile epiphyseal cartilage. The encoded protein undergoes proteolytic processing to generate a mature protein that is secreted into the extracellular matrix. The glutamic acid residues in the encoded protein undergo gamma carboxylation in a vitamin K-dependent manner. Undercarboxylation of the encoded protein is associated with osteoarthritis in humans. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.